Liver transplantationOutcomeComparison of Clinical and Pathological Staging and Long-Term Results of Liver Transplantation for Hepatocellular Carcinoma in a Single Transplant Center
Section snippets
Patients and methods
From 1996 to 2005, 50 patients underwent orthotopic liver transplantation (OLT), 48 from cadaveric and two from living donors, for HCC, accounting for 17.5% of all the primary indications for OLT performed at out center. There were 43 men (86%) and seven women (14%) of overall median age of 57 years (range 37 to 67). All patients fulfilled the Milan criteria at transplantation, since the policy of our center was to exclude HCC exceeding the Milan criteria. The diagnosis of HCC was based on
Results
Upon histological examination of the whole extirpated liver, we discovered 6 (12%) incidentalomas, while in 8 (16%) cases there was no HCC. Finally we had 42 “true” HCC based on pathological examination. Twenty-six patients (52%) were downstaged and 10 (20%) upstaged from the preoperative imaging based on pathological examination of the specimens. After transplantation 15% of patients were pT1; 45% were pT2; 27% pT3; and 13% pT4a. Thirty-one percent and 69% of patients showed monofocal and
Discussion
The appropriate selection criteria for patients with presumed or confirmed HCC depends on both the extent of disease and the degree of liver dysfunction. Preoperative staging continues to be controversial whether spiral CT or magnetic resonance imaging is the best imaging method.4 The importance of pretransplant tumor biopsy has recently been reemphasized, after a period of quiescence, in order to define the biologic behavior of the tumor.5 These criteria are currently used by UNOS for the
References (9)
Screening for hepatocellular carcinoma
Best Pract Res Clin Gastroenterol
(2005)- et al.
Liver transplantation for hepatocellular carcinomaexpansion of the tumor size limits does not adversely impact survival
Hepatology
(2001) - et al.
Focal lesions in cirrhotic explant liverspathological evaluation and accuracy of pretransplantation imaging examinations
Liver Transpl
(2002) - et al.
Opportunities for targeted therapies in hepatocellular carcinoma
J Clin Oncol
(2005)